Arrowhead Pharmaceuticals, Inc., based in Madison, WI, is a pioneering biopharmaceutical company specializing in developing innovative medicines to combat challenging diseases by targeting and silencing disease-causing genes. With a focus on RNA interference technology, Arrowhead's diverse pipeline includes treatments for a range of conditions such as liver disease, hypertriglyceridemia, dyslipidemia, and inflammatory disorders.
Utilizing a robust drug discovery platform and proprietary RNA chemistries, Arrowhead Pharmaceuticals aims to deliver effective therapies that induce rapid and long-lasting gene knockdown. With a strong emphasis on scientific expertise and cutting-edge technologies, the company is dedicated to advancing RNAi-based treatments to address unmet medical needs and improve patient outcomes.
Generated from the website